Smoking Cessation Program in the Construction Sector

Description

The main objective of this study is to identify the optimal adaptive smoking cessation program for the construction sector in terms of effectiveness, cost-effectiveness, and potential implementation.

Conditions

Smoking Cessation, Tobacco Use Cessation, Tobacco Smoking

Talk to us

Study Overview

On this page

Study Details

Study overview

The main objective of this study is to identify the optimal adaptive smoking cessation program for the construction sector in terms of effectiveness, cost-effectiveness, and potential implementation.

Expanding the Role of the Safety Manager to Implement a Workplace Smoking Cessation Program in the Construction Sector

Smoking Cessation Program in the Construction Sector

Condition
Smoking Cessation
Intervention / Treatment

-

Contacts and Locations

Miami

Don Soffer Clinical Research Center, Miami, Florida, United States, 33136

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * ≥ 18 years
  • * Involved in decision making
  • * Willing to participate in the implementation development and evaluation
  • * ≥ 18 years
  • * Be a safety manager
  • * No plans to leave the company within the next year
  • * Bilingual
  • * Willing to receive training in smoking cessation treatment
  • * Willing to deliver the smoking cessation treatment to workers
  • * Be a construction worker
  • * ≥ 18 years
  • * Have smoked on average 5 or more cigarettes daily for the past year
  • * Willing to make a serious quit attempt in the next 30 days
  • * Planning to stay in the company for the next 6 months
  • * Own a telephone and plan to keep it active for the next 12 months

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Miami,

Taghrid Asfar, MD, PRINCIPAL_INVESTIGATOR, tasfar@miami.edu

Study Record Dates

2027-02-28